e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Clinical challenges in respiratory infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predicting outcomes for invasive fungal tracheobronchitis
C. Lin (Taoyuan, Taiwan), Y. Fang (Taoyuan, Taiwan)
Source:
International Congress 2018 – Clinical challenges in respiratory infection
Session:
Clinical challenges in respiratory infection
Session type:
Thematic Poster
Number:
4690
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Lin (Taoyuan, Taiwan), Y. Fang (Taoyuan, Taiwan). Predicting outcomes for invasive fungal tracheobronchitis. 4690
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Comparison of clinical characteristics of invasive tracheobronchial aspergillosis with or without invasive pulmonary aspergillosis
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
Lung resection for invasive pulmonary aspergillosis in neutropenic patients – risks and outcome
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Invasive pulmonary aspergillosis in patients with severe COPD. Compative study between probable invasive infection and colonization
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Prediction of prognosis in healthcare-associated pneumonia
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
I like invasive techniques to define their role in the diagnosis of pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009
Prediction of complications development and lethal outcome in patients with community-acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
Fungal lung infections in critically-ill patients
Source: International Congress 2016 – PG19 The lung in the septic critically-ill patient
Year: 2016
Biomarkers in severe community-acquired pneumonia (SCAP) prognosis, complications and outcomes
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 310s
Year: 2006
Cytokine responses, microbial etiology and short-term outcome in community-acquired pneumonia
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections
Source: Eur Respir Monogr 2020; 88: 212-228
Year: 2020
Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome
Source: Eur Respir J 2014; 43: 1698-1708
Year: 2014
Clinical features of invasive pulmonary aspergillosis in critical ill patients with chronic respiratory disease
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis
Source: Eur Respir J , 49 (2) 1602520; DOI: 10.1183/13993003.02520-2016
Year: 2017
Predicting risk of mortality of chronic pulmonary aspergillosis
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020
Update on preventing and managing hospital-acquired and ventilatory-associated pneumonia
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
Source: Eur Respir J 2004; 24: Suppl. 48, 548s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept